Erratum: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated (PLoS ONE (2022) 17:3 (e0266175) DOI: 10.1371/journal.pone.0266175)

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are errors in the author affiliations. The publisher apologizes for the errors. The correct affiliations are as follows: Ahmed Samir Abdelhafiz1, Asmaa Ali2,6, Ayman Mohamed Maaly3, Mohamed Anwar Mahgoub4, Hany Hassan Ziady5, Eman Anwar Sultan5 1 Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt, 2 Department of Pulmonary Medicine, Abbassia Chest Hospital, MOH, Cairo, Egypt, 3 Department of Anaesthesia and Surgical Intensive Care, Faculty of Medicine, Alexandria University, Alexandria, Egypt, 4 Department of Microbiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt, 5 Department of Community Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt, 6 Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.

Cite

CITATION STYLE

APA

Abdelhafiz, A. S., Ali, A., Maaly, A. M., Mahgoub, M. A., Ziady, H. H., & Sultan, E. A. (2022, July 1). Erratum: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated (PLoS ONE (2022) 17:3 (e0266175) DOI: 10.1371/journal.pone.0266175). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0271154

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free